E-cadherin autoantibody profile in patients with pemphigus vulgaris

British Journal of Dermatology

Volumn 169, Issue 4, 2013, Pages 812-818

  Oliveira, M E F ^a,b   Culton, D A ^a   Prisayanh, P ^a   Qaqish, B F ^c   Diaz, L A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3 ANTIBODY; E CADHERIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MUCOCUTANEOUS PEMPHIGUS VULGARIS; MUCOSAL PEMPHIGUS VULGARIS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; WESTERN BLOTTING;

AUTOANTIBODIES; BLOTTING, WESTERN; CADHERINS; CASE-CONTROL STUDIES; DESMOGLEIN 1; DESMOGLEIN 3; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; IMMUNOPRECIPITATION; PEMPHIGUS;

EID: 84885658549     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12455     Document Type: Article

References (25)

1. Green KJ, Getsios S, Troyanovsky S, Godsel LM,. Intercellular junction assembly, dynamics, and homeostasis. Cold Spring Harb Perspect Biol 2010; 2: a000125.
2. Saito M, Tucker DK, Kohlhorst D, et al,. Classical and desmosomal cadherins at a glance. J Cell Sci 2012; 125: 2547-52.
3. Brooke M, Nitoiu D, Kelsell D,. Cell-cell connectivity: desmosomes and disease. J Pathol 2012; 226: 158-71.
4. Amagai M, Stanley JR,. Desmoglein as a target in skin disease and beyond. J Invest Dermatol 2012; 132: 776-84.
5. Lever WF,. Pemphigus. Medicine (Baltimore) 1953; 32: 1-123.
6. Amagai M, Klaus-Kovtum V, Stanley JR,. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris: a disease of cell adhesion. Cell 1991; 67: 869-77.
7. Anhalt GJ, Labib RS, Voorhees JJ, et al,. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 1982; 306: 1189-96.
8. Roscoe JT, Diaz LA, Sampaio SA, et al,. Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J Invest Dermatol 1985; 85: 538-41.
9. Rock B, Martins CR, Theofilopoulos AN, et al,. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med 1989; 320: 1463-9.
10. Ding Z, Aoki V, Mascaro JM Jr, et al,. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J Invest Dermatol 1997; 109: 592-6.
11. Amagai M, Tsumoda K, Zillikens D, et al,. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999; 40: 167-70.
12. Takahashi Y, Patel HP, Labib RS, et al,. Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes. J Invest Dermatol 1985; 84: 41-6.
13. Evangelista F, Dasher D, Diaz LA, et al,. E-cadherin is an additional immunological target for pemphigus autoantibodies. J Invest Dermatol 2008; 128: 1710-18.
14. Flores G, Culton DA, Prisayanh P, et al,. IgG autoantibody response against keratinocyte cadherins in endemic pemphigus foliaceus. J Invest Dermatol 2012; 132: 2573-80.
15. Li N, Aoki V, Hans-Filho G, et al,. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J Exp Med 2003; 197: 1501-10.
16. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2012.
17. Simpson CL, Patel DM, Green KJ,. Deconstructing the skin: cytoarchitectural determinants of epidermal morphogenesis. Nat Rev Mol Cell Biol 2011; 12: 565-80.
18. Sharma P, Mao X, Payne A,. Beyond steric hindrance: the role of adhesion signaling pathways in the pathogenesis of pemphigus. J Dermatol Sci 2007; 48: 1-14.
19. Muller EJ, Williamson L, Kolly C, Suter MM,. Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation? J Invest Dermatol 2008; 128: 501-16.
20. Fedor-Chaiken M, Hein PW, Stewart JC, et al,. E-cadherin binding modulates EGF receptor activation. Cell Commun Adhes 2003; 10: 105-18.
21. Getsios S, Simpson CL, Kojima S, et al,. Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol 2009; 185: 1243-58.
22. Koga H, Ohyama B, Tsuruta D, et al,. Five Japanese cases of antidesmoglein 1 antibody-positive and antidesmoglein 3 antibody-negative pemphigus with oral lesions. Br J Dermatol 2012; 166: 976-80.
23. Jamora MJ, Jiao D, Bystryn JC,. Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. J Am Acad Dermatol 2003; 48: 976-7.
24. Sharma V, Prasad HRY, Khandpur S, Kumar A,. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris. Int J Dermatol 2006; 45: 518-22.
25. Belloni-Fortine A, Faggion D, Pigozzi B, et al,. Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up. Clin Dev Immunol 2009; 2009: 187864.